Type
Internal restructuring
Country
World
Region
Location of affected unit(s)
Germany, Austria, Switzerland, USA
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

4,800 jobs
Number of planned job losses
Job loss
Announcement Date
17 November 2010
Employment effect (start)
18 November 2010
Foreseen end date
31 December 2012

Description

The Switzerland-based pharmaceutical company Roche has announced that it is to reduce its workforce by 4,800 positions over the next two years. The largest reductions will be in sales, marketing and manufacturing.

The European factories in Mannheim and Kulmbach (Germany) will be heavily affected. Also, plants in Graz (Austria) and Burgdorf (Switzerland) will be closed. The redundancies are part of the ‘Operational Excellence Program' of the pharmaceutical company, aiming at reducing costs.

On top of the job reductions, 800 jobs will be transferred to other Roche sites and 700 positions outsourced to third parties. Combination of announced job reductions and transfers will affect 6,300 positions.


Sources

Citation

Eurofound (2010), Roche, Internal restructuring in World, factsheet number 71189, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/71189.